Karl Eduard Schneweis

Title: Karl Eduard Schneweis: Innovator in Anti-HSV Antibodies

Introduction

Karl Eduard Schneweis is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HSV antibodies. With a total of 2 patents, his work has the potential to impact the treatment of HSV-associated diseases.

Latest Patents

Schneweis's latest patents focus on an anti-HSV antibody. The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising an effective amount of the said antibody, an expression vector comprising a nucleotide sequence that encodes the said antibody, a host cell comprising the said nucleotide sequence, and a hybridoma cell capable of producing the said antibody. The use of this antibody as a drug, particularly for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject, is also defined in the claims.

Career Highlights

Throughout his career, Karl Eduard Schneweis has worked with prominent organizations such as Heidelberg Immunotherapeutics GmbH and Universität Duisburg Essen. His experience in these institutions has contributed to his expertise in the field of immunotherapy and antibody development.

Collaborations

Some of his notable coworkers include Michael Roggendorf and Anna-Maria Eis-Hübinger. Their collaborative efforts have likely enhanced the research and development of innovative solutions in the field.

Conclusion

Karl Eduard Schneweis stands out as an influential inventor in the realm of anti-HSV antibodies. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving treatment options for HSV-associated diseases.